Skip to main content
Erschienen in: AIDS and Behavior 2/2018

07.07.2017 | Original Paper

Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men

verfasst von: José A. Bauermeister, R. Giguere, C. S. Leu, C. Dolezal, I. Febo, R. D. Cranston, K. Mayer, I. McGowan, A. Carballo-Diéguez

Erschienen in: AIDS and Behavior | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

We examined young gay, bisexual, and other men who have sex with men’s (YGBMSM) usage patterns of a pre-coital, applicator-administered rectal placebo gel. An ethnically diverse sample of 94 YGBMSM (aged 18–30 years) were asked to insert hydroxyethylcellulose placebo gel rectally before receptive anal intercourse (RAI) and report their gel use through an interactive voice response system (IVRS) across 12 weeks. We used trajectory analyses to characterize participants’ use of the rectal gel over the 12 weeks, and examine whether these trajectories varied based on participants’ sociodemographic characteristics, sexual behaviors, application and insertion behaviors, and experiences using the placebo gel. A cubic model was the best fit for these longitudinal data, with two distinct trajectories of gel use observed. The first trajectory (‘High with Varying Gel Use per Week’) represented YGBMSM (N = 38; 40.3%) who reported using the rectal gel on several occasions per week. The second trajectory (‘Low and Consistent Gel Use per Week’) represented participants (N = 56; 59.7%) who reported a consistent average use of one gel per week. Participants in the High with Varying Gel Use Trajectory reported trying out a greater number of positions when inserting the gel across the 12-weeks than peers in the Low and Consistent Gel Use Trajectory. YGBMSM reporting more RAI occasions during the trial were more likely be present in the High with Varying Gel Use Trajectory than peers in the Low and Consistent Gel Use Trajectory. Future research examining how to facilitate gel application and adherence among YGBMSM is merited.
Literatur
2.
Zurück zum Zitat McGowan I. Rectal microbicides: can we make them and will people use them? AIDS Behav. 2011;15(Suppl 1):66–71.CrossRef McGowan I. Rectal microbicides: can we make them and will people use them? AIDS Behav. 2011;15(Suppl 1):66–71.CrossRef
3.
Zurück zum Zitat Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210–9.CrossRefPubMedPubMedCentral Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat McGowan I. The development of rectal microbicides for HIV prevention. Expert Opin Drug Deliv. 2014;11:69–82.CrossRefPubMed McGowan I. The development of rectal microbicides for HIV prevention. Expert Opin Drug Deliv. 2014;11:69–82.CrossRefPubMed
5.
Zurück zum Zitat Carballo-Diéguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.CrossRefPubMedPubMedCentral Carballo-Diéguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.CrossRefPubMed Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.CrossRefPubMed
7.
Zurück zum Zitat Tang E, Galea JT, Kinsler JJ, Gonzales P, Sobieszczyk ME, Sanchez J, Lama J. Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men. Sex Transm Infect. 2015;92(3):200–5.CrossRefPubMed Tang E, Galea JT, Kinsler JJ, Gonzales P, Sobieszczyk ME, Sanchez J, Lama J. Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men. Sex Transm Infect. 2015;92(3):200–5.CrossRefPubMed
8.
Zurück zum Zitat Mantell JE, Myer L, Carballo-Diéguez A, Stein Z, Ramjee G, Morar NS, Harrison PF. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60(2):319–30.CrossRefPubMed Mantell JE, Myer L, Carballo-Diéguez A, Stein Z, Ramjee G, Morar NS, Harrison PF. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60(2):319–30.CrossRefPubMed
9.
Zurück zum Zitat Gorbach PM, Kelly CW, Borgerding J, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L. Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035). AIDS Behav. 2014;18(5):855–61.CrossRefPubMedPubMedCentral Gorbach PM, Kelly CW, Borgerding J, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L. Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035). AIDS Behav. 2014;18(5):855–61.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Van Der Straten A, Montgomery ET, Cheng H, Wegner L, Masenga G, Von Mollendorf C, Bekker L, Ganesh S, Young K, Romano J, Nel A, Woodsong C. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 2012;16(7):1775–86.CrossRefPubMed Van Der Straten A, Montgomery ET, Cheng H, Wegner L, Masenga G, Von Mollendorf C, Bekker L, Ganesh S, Young K, Romano J, Nel A, Woodsong C. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 2012;16(7):1775–86.CrossRefPubMed
11.
Zurück zum Zitat Clark JL, Salvatierra HJ, Segura ER, Salazar X, Konda K, Galea J, Klausner JD, Coates TJ, Caceres C. Frequency, patterns, and preferences of lubricant use during anal intercourse within male sexaul partnerships in Lima, Peru: implications for a rectal microbicide HIV prevention intervention. AIDS Care. 2013;25:579–85.CrossRefPubMed Clark JL, Salvatierra HJ, Segura ER, Salazar X, Konda K, Galea J, Klausner JD, Coates TJ, Caceres C. Frequency, patterns, and preferences of lubricant use during anal intercourse within male sexaul partnerships in Lima, Peru: implications for a rectal microbicide HIV prevention intervention. AIDS Care. 2013;25:579–85.CrossRefPubMed
12.
Zurück zum Zitat Murphy DA, Lea T, de Wit J, Ellard JM, Kippax SC, Rosengarten M, Holt M. Interest in using rectal microbicides among Australian gay men is associated with HIV vulnerability and engaging in condomless sex with casual partners: results from a national study. Sex Transm Infect. 2015;91:266–8.CrossRefPubMed Murphy DA, Lea T, de Wit J, Ellard JM, Kippax SC, Rosengarten M, Holt M. Interest in using rectal microbicides among Australian gay men is associated with HIV vulnerability and engaging in condomless sex with casual partners: results from a national study. Sex Transm Infect. 2015;91:266–8.CrossRefPubMed
13.
Zurück zum Zitat Pines HA, Gorbach PM, Weiss RE, Hess K, Murphy R, Saunders T, Brown J, Anton PA, Cranston RD. Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial. AIDS Behav. 2013;17(3):1002–15.CrossRefPubMedPubMedCentral Pines HA, Gorbach PM, Weiss RE, Hess K, Murphy R, Saunders T, Brown J, Anton PA, Cranston RD. Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial. AIDS Behav. 2013;17(3):1002–15.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Newman P, Roungprakhon S, Tepjan S. A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thalian. J Int AIDS Soc. 2013;16:18476.CrossRefPubMedPubMedCentral Newman P, Roungprakhon S, Tepjan S. A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thalian. J Int AIDS Soc. 2013;16:18476.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Morrow KM, Ruiz MS. Assessing microbicide acceptability: a comprehensive and integrated approach. AIDS Behav. 2008;12(2):272–83.CrossRefPubMed Morrow KM, Ruiz MS. Assessing microbicide acceptability: a comprehensive and integrated approach. AIDS Behav. 2008;12(2):272–83.CrossRefPubMed
16.
Zurück zum Zitat Bauermeister JA, Giguere R, Dolezal C, Leu CS, Febo RD, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. To use a rectal microbicide, first insert the applicator: gel and applicator satisfaction among young men who have sex with men. AIDS Educ Prev. 2016;28(1):1–10.CrossRefPubMedPubMedCentral Bauermeister JA, Giguere R, Dolezal C, Leu CS, Febo RD, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. To use a rectal microbicide, first insert the applicator: gel and applicator satisfaction among young men who have sex with men. AIDS Educ Prev. 2016;28(1):1–10.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lin AH, Breger TL, Barnhart M, Kim A, Vangsgaard C, Harris E. Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning. J Int AIDS Soc. 2014;17(Suppl 2):19162.PubMedPubMedCentral Lin AH, Breger TL, Barnhart M, Kim A, Vangsgaard C, Harris E. Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning. J Int AIDS Soc. 2014;17(Suppl 2):19162.PubMedPubMedCentral
18.
Zurück zum Zitat McGowan I, Cranston RD, Mayer KH, Febo I, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Park SY, Brand RM, Jacobson C, Giguere R, Dolezal C, Frasca T, Leu CS, Schwartz JL, Carballo-Dieguez A. Project Gel: a randomized rectal microbicide safety and acceptability study in young men and transgender women. PLoS ONE. 2016;11(6):e0158310.CrossRefPubMedPubMedCentral McGowan I, Cranston RD, Mayer KH, Febo I, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Park SY, Brand RM, Jacobson C, Giguere R, Dolezal C, Frasca T, Leu CS, Schwartz JL, Carballo-Dieguez A. Project Gel: a randomized rectal microbicide safety and acceptability study in young men and transgender women. PLoS ONE. 2016;11(6):e0158310.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Carballo-Dieguez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Frasca T, Labbett R, Cranston RD, Febo I, Mayer K, McGowan I. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research. AIDS Behav. 2014;18(9):1726–33.CrossRefPubMedPubMedCentral Carballo-Dieguez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Frasca T, Labbett R, Cranston RD, Febo I, Mayer K, McGowan I. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research. AIDS Behav. 2014;18(9):1726–33.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Bauermeister JA, Giguere R, Leu CS, Febo I, Cranston R, Mayer K, McGowan I, Carballo-Dieguez A. Interactive voice response system: data considerations and lessons learned during a rectal microbicide placebo adherence trial for young men who have sex with men. J Med Internet Res. 2017;19(6):e207.CrossRefPubMedPubMedCentral Bauermeister JA, Giguere R, Leu CS, Febo I, Cranston R, Mayer K, McGowan I, Carballo-Dieguez A. Interactive voice response system: data considerations and lessons learned during a rectal microbicide placebo adherence trial for young men who have sex with men. J Med Internet Res. 2017;19(6):e207.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nagin D. Analyzing developmental trajectories: a semiparametric, group-based approach. Psychol Methods. 1999;4(2):139–57.CrossRef Nagin D. Analyzing developmental trajectories: a semiparametric, group-based approach. Psychol Methods. 1999;4(2):139–57.CrossRef
23.
Zurück zum Zitat Janulis P, Feinstein BA, Phillips G, Newcomb M, Birkett M, Mustanski B. Sexual partner typologies and the association between drug use and sexual risk behavior among young men who have sex with men. Arch Sex Behav. 2017;. doi:10.1007/s10508-016-0909-x. Janulis P, Feinstein BA, Phillips G, Newcomb M, Birkett M, Mustanski B. Sexual partner typologies and the association between drug use and sexual risk behavior among young men who have sex with men. Arch Sex Behav. 2017;. doi:10.​1007/​s10508-016-0909-x.
24.
Zurück zum Zitat Giguere R, Dolezal C, Bauermeister JA, Frasca T, Valladares J, Febo I, Cranston R, Mayer K, McGowan I, Carballo-Dieguez A. Influence of partner type on acceptability and likelihood of use of a rectal microbicide among young men who have sex with men in the United States and Puerto Rico. J Sex Res. 2016;53(6):633–41.CrossRefPubMed Giguere R, Dolezal C, Bauermeister JA, Frasca T, Valladares J, Febo I, Cranston R, Mayer K, McGowan I, Carballo-Dieguez A. Influence of partner type on acceptability and likelihood of use of a rectal microbicide among young men who have sex with men in the United States and Puerto Rico. J Sex Res. 2016;53(6):633–41.CrossRefPubMed
25.
Zurück zum Zitat Mitchell JW, Sophus A, Lee JY, Petroll A. Anal douche practices and willingness to use a rectal microbicide enema for HIV prevention and associated factors among an internet sample of HIV-negative and HIV-discordant male couples in the US. AIDS Behav. 2016;20(11):2578–87.CrossRefPubMedPubMedCentral Mitchell JW, Sophus A, Lee JY, Petroll A. Anal douche practices and willingness to use a rectal microbicide enema for HIV prevention and associated factors among an internet sample of HIV-negative and HIV-discordant male couples in the US. AIDS Behav. 2016;20(11):2578–87.CrossRefPubMedPubMedCentral
Metadaten
Titel
Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men
verfasst von
José A. Bauermeister
R. Giguere
C. S. Leu
C. Dolezal
I. Febo
R. D. Cranston
K. Mayer
I. McGowan
A. Carballo-Diéguez
Publikationsdatum
07.07.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 2/2018
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1847-x

Weitere Artikel der Ausgabe 2/2018

AIDS and Behavior 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.